Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Nature Biotechnology volume 26, pages 101–106 (2008)Cite this article

Abstract

Direct reprogramming of somatic cells provides an opportunity to generate patient- or disease-specific pluripotent stem cells. Such induced pluripotent stem (iPS) cells were generated from mouse fibroblasts by retroviral transduction of four transcription factors: Oct3/4, Sox2, Klf4 and c-Myc1. Mouse iPS cells are indistinguishable from embryonic stem (ES) cells in many respects and produce germline-competent chimeras2,3,4. Reactivation of the c-Myc retrovirus, however, increases tumorigenicity in the chimeras and progeny mice, hindering clinical applications3. Here we describe a modified protocol for the generation of iPS cells that does not require the Myc retrovirus. With this protocol, we obtained significantly fewer non-iPS background cells, and the iPS cells generated were consistently of high quality. Mice derived from Myc− iPS cells did not develop tumors during the study period. The protocol also enabled efficient isolation of iPS cells without drug selection. Furthermore, we generated human iPS cells from *** dermal fibroblasts without MYC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Effect of family factors and omission of Myc on the generation of iPS cells from Nanog-reporter MEFs.
Figure 2: Generation of iPS cells without the Myc retrovirus from MEFs containing the Fbxo15 reporter and the constitutively active GFP transgene.
Figure 3: The efficient isolation of iPS cells without drug selection.
Figure 4: Generation of human iPS cells without the MYC retrovirus.

Similar content being viewed by others

References

  1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and *** fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

    Article  CAS  Google Scholar 

  2. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES cell-like state. Nature 448, 318–324 (2007).

    Article  CAS  Google Scholar 

  3. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germ-line competent induced pluripotent stem cells. Nature 448, 313–317 (2007).

    Article  CAS  Google Scholar 

  4. Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).

    Article  CAS  Google Scholar 

  5. Chambers, I. et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).

    Article  CAS  Google Scholar 

  6. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631–642 (2003).

    Article  CAS  Google Scholar 

  7. Ryan, A.K. & Rosenfeld, M.G. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 11, 1207–1225 (1997).

    Article  CAS  Google Scholar 

  8. Schepers, G.E., Teasdale, R.D. & Koopman, P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev. Cell 3, 167–170 (2002).

    Article  CAS  Google Scholar 

  9. Dang, D.T., Pevsner, J. & Yang, V.W. The biology of the mammalian Kruppel-like family of transcription factors. Int. J. Biochem. Cell Biol. 32, 1103–1121 (2000).

    Article  CAS  Google Scholar 

  10. Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635–645 (2005).

    Article  CAS  Google Scholar 

  11. Tokuzawa, Y. et al. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23, 2699–2708 (2003).

    Article  CAS  Google Scholar 

  12. Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063–1066 (2000).

    Article  CAS  Google Scholar 

  13. Vintersten, K. et al. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and *** animals. Genesis 40, 241–246 (2004).

    Article  CAS  Google Scholar 

  14. Takahashi, K. et al. Induction of pluripotent stem cells from *** human fibroblasts by defined factors. Cell, published online, doi:10.1016/j.cell.2007.11.019 (20 November 2007).

  15. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science, published online, doi:10.1126/science.1151526 (20 November 2007).

  16. Polesskaya, A. et al. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 21, 1125–1138 (2007).

    Article  CAS  Google Scholar 

  17. McMahon, A.P. & Bradley, A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1073–1085 (1990).

    Article  CAS  Google Scholar 

  18. Meiner, V.L. et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA 93, 14041–14046 (1996).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank K. Yae and M. Maekawa for their valuable scientific discussions; M. Narita for technical assistance; and R. Kato and R. Iyama for administrative assistance. We also thank K. Tomoda for the RNA of hES cells, T. Kitamura for the Plat-E cells and pMXs retroviral vectors, and R. Farese for the RF8 ES cells. This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO, a grant from the Leading Project of MEXT, a grant from Uehara Memorial Foundation and Grants-in-Aid for Scientific Research of JSPS and MEXT (to S.Y.). T. A. and K.O. are JSPS research fellows.

Author information

Author notes

  1. Masato Nakagawa and Michiyo Koyanagi: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan

    Masato Nakagawa, Michiyo Koyanagi, Koji Tanabe, Kazutoshi Takahashi, Tomoko Ichisaka, Takashi Aoi, Keisuke Okita, Yuji Mochiduki, Nanako Takizawa & Shinya Yamanaka

  2. CREST, Japan Science and Technology Agency, Kawaguchi, 332-0012, Japan

    Tomoko Ichisaka & Shinya Yamanaka

  3. Gladstone Institute of Cardiovascular Disease, San Francisco, 94158, CA, USA

    Shinya Yamanaka

  4. Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, 606-8507, Japan

    Shinya Yamanaka

Authors
  1. Masato Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michiyo Koyanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Koji Tanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazutoshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomoko Ichisaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takashi Aoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keisuke Okita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuji Mochiduki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nanako Takizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shinya Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.N., M.K., K.Tanabe, K.Takahashi, T.A. and K.O. generated and characterized iPS cells. T.I. performed the chimera experiments. Y.M. prepared plasmids. N.T. characterized iPS cells. S.Y. supervised the study and wrote the manuscript.

Corresponding author

Correspondence to Shinya Yamanaka.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1–3 and Figures 1–3 (PDF 2890 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakagawa, M., Koyanagi, M., Tanabe, K. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101–106 (2008). https://doi.org/10.1038/nbt1374

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1374

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing